Cargando…

The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019

BACKGROUND: Pneumoconiosis refers to a class of serious diseases threatening the health of workers exposed to coal or silicosis dust. However, the burden of pneumoconiosis is unavailable in China. METHODS: Incident cases, deaths, and disability-adjusted life years (DALYs) from pneumoconiosis and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Yin, Peng, Wang, Haidong, Wang, Lijun, You, Jinling, Liu, Jiangmei, Liu, Yunning, Wang, Wei, Zhang, Xiao, Niu, Piye, Zhou, Maigeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166455/
https://www.ncbi.nlm.nih.gov/pubmed/35659279
http://dx.doi.org/10.1186/s12889-022-13541-x
_version_ 1784720606940364800
author Li, Jie
Yin, Peng
Wang, Haidong
Wang, Lijun
You, Jinling
Liu, Jiangmei
Liu, Yunning
Wang, Wei
Zhang, Xiao
Niu, Piye
Zhou, Maigeng
author_facet Li, Jie
Yin, Peng
Wang, Haidong
Wang, Lijun
You, Jinling
Liu, Jiangmei
Liu, Yunning
Wang, Wei
Zhang, Xiao
Niu, Piye
Zhou, Maigeng
author_sort Li, Jie
collection PubMed
description BACKGROUND: Pneumoconiosis refers to a class of serious diseases threatening the health of workers exposed to coal or silicosis dust. However, the burden of pneumoconiosis is unavailable in China. METHODS: Incident cases, deaths, and disability-adjusted life years (DALYs) from pneumoconiosis and its subtypes in China were estimated from the Global Burden of Disease Study 2019 using a Bayesian meta-regression method. The trend of the burden from pneumoconiosis was analyzed using percentage change and annualized rate of change (ARC) during the period 1990–2019. The relationship between subnational socio-demographic index (SDI) and the ARC of age-standardised death rate was measured using Spearman’s Rank-Order Correlation. RESULTS: In 2019, there were 136.8 (95% uncertainty interval [UI] 113.7–162.5) thousand new cases, 10.2 (8.1–13.6) thousand deaths, and 608.7 (473.6–779.4) thousand DALYs from pneumoconiosis in China. Of the global burdens from pneumoconiosis, more than 60% were in China. Both the total number of new cases and DALYs from pneumoconiosis was keeping increasing from 1990 to 2019. In contrast, the age-standardised incidence, death, and DALY rates from pneumoconiosis and its subtypes, except for the age-standardised incidence rate of silicosis, and age-standardised death rate of asbestosis, experienced a significant decline during the same period. The subnational age-standardised death rates were higher in western China than in eastern China. Meanwhile, the subnational ARC of age-standardised death rates due to pneumoconiosis and its subtypes were significantly negatively correlated with SDI in 2019. CONCLUSION: China suffers the largest health loss from pneumoconiosis in the world. Reducing the burden of pneumoconiosis is still an urgent task in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13541-x.
format Online
Article
Text
id pubmed-9166455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91664552022-06-05 The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019 Li, Jie Yin, Peng Wang, Haidong Wang, Lijun You, Jinling Liu, Jiangmei Liu, Yunning Wang, Wei Zhang, Xiao Niu, Piye Zhou, Maigeng BMC Public Health Research BACKGROUND: Pneumoconiosis refers to a class of serious diseases threatening the health of workers exposed to coal or silicosis dust. However, the burden of pneumoconiosis is unavailable in China. METHODS: Incident cases, deaths, and disability-adjusted life years (DALYs) from pneumoconiosis and its subtypes in China were estimated from the Global Burden of Disease Study 2019 using a Bayesian meta-regression method. The trend of the burden from pneumoconiosis was analyzed using percentage change and annualized rate of change (ARC) during the period 1990–2019. The relationship between subnational socio-demographic index (SDI) and the ARC of age-standardised death rate was measured using Spearman’s Rank-Order Correlation. RESULTS: In 2019, there were 136.8 (95% uncertainty interval [UI] 113.7–162.5) thousand new cases, 10.2 (8.1–13.6) thousand deaths, and 608.7 (473.6–779.4) thousand DALYs from pneumoconiosis in China. Of the global burdens from pneumoconiosis, more than 60% were in China. Both the total number of new cases and DALYs from pneumoconiosis was keeping increasing from 1990 to 2019. In contrast, the age-standardised incidence, death, and DALY rates from pneumoconiosis and its subtypes, except for the age-standardised incidence rate of silicosis, and age-standardised death rate of asbestosis, experienced a significant decline during the same period. The subnational age-standardised death rates were higher in western China than in eastern China. Meanwhile, the subnational ARC of age-standardised death rates due to pneumoconiosis and its subtypes were significantly negatively correlated with SDI in 2019. CONCLUSION: China suffers the largest health loss from pneumoconiosis in the world. Reducing the burden of pneumoconiosis is still an urgent task in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13541-x. BioMed Central 2022-06-03 /pmc/articles/PMC9166455/ /pubmed/35659279 http://dx.doi.org/10.1186/s12889-022-13541-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Jie
Yin, Peng
Wang, Haidong
Wang, Lijun
You, Jinling
Liu, Jiangmei
Liu, Yunning
Wang, Wei
Zhang, Xiao
Niu, Piye
Zhou, Maigeng
The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title_full The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title_fullStr The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title_full_unstemmed The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title_short The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019
title_sort burden of pneumoconiosis in china: an analysis from the global burden of disease study 2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166455/
https://www.ncbi.nlm.nih.gov/pubmed/35659279
http://dx.doi.org/10.1186/s12889-022-13541-x
work_keys_str_mv AT lijie theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT yinpeng theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wanghaidong theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wanglijun theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT youjinling theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT liujiangmei theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT liuyunning theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wangwei theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT zhangxiao theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT niupiye theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT zhoumaigeng theburdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT lijie burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT yinpeng burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wanghaidong burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wanglijun burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT youjinling burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT liujiangmei burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT liuyunning burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT wangwei burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT zhangxiao burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT niupiye burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019
AT zhoumaigeng burdenofpneumoconiosisinchinaananalysisfromtheglobalburdenofdiseasestudy2019